A DBS neuromodulation approach of the ARC to treat obesity would preferably activate selectively the anorexigenic POMC and/or inactivate the orexigenic AgRP/NPY neurons. Here, AGRP is linked to obesity due to melanocortin 4 receptor deficiency.